Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:O15079 (
syntaphilin
)
37
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proper distribution of mitochondria within axons and at synapses is critical for neuronal function. While one-third of
axonal
mitochondria are mobile, a large proportion remains in a stationary phase. However, the mechanisms controlling mitochondrial docking within axons remain elusive. Here, we report a role for axon-targeted
syntaphilin
(
SNPH
) in mitochondrial docking through its interaction with microtubules. Axonal mitochondria that contain exogenously or endogenously expressed
SNPH
lose mobility. Deletion of the mouse snph gene results in a substantially higher proportion of
axonal
mitochondria in the mobile state and reduces the density of mitochondria in axons. The snph mutant neurons exhibit enhanced short-term facilitation during prolonged stimulation, probably by affecting calcium signaling at presynaptic boutons. This phenotype is fully rescued by reintroducing the snph gene into the mutant neurons. These findings demonstrate a molecular mechanism for controlling mitochondrial docking in axons that has a physiological impact on synaptic function.
...
PMID:Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. 1819 Dec 27
Multiple sclerosis is the most common cause of non-traumatic neurological impairment in young adults. An energy deficient state has been implicated in the degeneration of axons, the pathological correlate of disease progression, in multiple sclerosis. Mitochondria are the most efficient producers of energy and play an important role in calcium homeostasis. We analysed the density and function of mitochondria using immunohistochemistry and histochemistry, respectively, in chronic active and inactive lesions in progressive multiple sclerosis. As shown before in acute pattern III and Balo's lesions, the mitochondrial respiratory chain complex IV activity is reduced despite the presence of mitochondria in demyelinated axons with amyloid precursor protein accumulation, which are predominantly located at the active edge of chronic active lesions. Furthermore, the strong non-phosphorylated neurofilament (SMI32) reactivity was associated with a significant reduction in complex IV activity and mitochondria within demyelinated axons. The complex IV defect associated with
axonal
injury may be mediated by soluble products of innate immunity, as suggested by an inverse correlation between complex IV activity and macrophage/microglial density in chronic lesions. However, in inactive areas of chronic multiple sclerosis lesions the mitochondrial respiratory chain complex IV activity and mitochondrial mass, judged by porin immunoreactivity, are increased within approximately half of large (>2.5 microm diameter) chronically demyelinated axons compared with large myelinated axons in the brain and spinal cord. The axon-specific mitochondrial docking protein (
syntaphilin
) and phosphorylated neurofilament-H were increased in chronic lesions. The lack of complex IV activity in a proportion of Na(+)/K(+) ATPase alpha-1 positive demyelinated axons supports
axonal
dysfunction as a contributor to neurological impairment and disease progression. Furthermore, in vitro studies show that inhibition of complex IV augments glutamate-mediated
axonal
injury (amyloid precursor protein and SMI32 reactivity). Our findings have important implications for both
axonal
degeneration and dysfunction during the progressive stage of multiple sclerosis.
...
PMID:Mitochondrial changes within axons in multiple sclerosis. 1929 37
Mitochondria in the cell bodies of neurons are transported down neuronal processes in response to changes in local energy and metabolic states. Because of their extreme polarity, neurons require specialized mechanisms to regulate mitochondrial transport and retention in axons. Our previous studies using
syntaphilin
(snph) knock-out mice provided evidence that
SNPH
targets to
axonal
mitochondria and controls their mobility through its static interaction with microtubules (MTs). However, the mechanisms regulating
SNPH
-mediated mitochondrial docking remain elusive. Here, we report an unexpected role for dynein light chain LC8. Using proteomic biochemical and cell biological assays combined with time-lapse imaging in live snph wild-type and mutant neurons, we reveal that LC8 regulates
axonal
mitochondrial mobility by binding to
SNPH
, thus enhancing the
SNPH
-MT docking interaction. Using mutagenesis assays, we mapped a seven-residue LC8-binding motif. Through this specific interaction,
SNPH
recruits LC8 to
axonal
mitochondria; such colocalization is abolished when neurons express
SNPH
mutants lacking the LC8-binding motif. Transient LC8 expression reduces mitochondrial mobility in snph (+/+) but not (-/-) neurons, suggesting that the observed effect of LC8 depends on the
SNPH
-mediated docking mechanism. In contrast, deleting the LC8-binding motif impairs the ability of
SNPH
to immobilize
axonal
mitochondria. Furthermore, circular dichroism spectrum analysis shows that LC8 stabilizes an alpha-helical coiled-coil within the MT-binding domain of
SNPH
against thermal unfolding. Thus, our study provides new mechanistic insights into controlling mitochondrial mobility through a dynamic interaction between the mitochondrial docking receptor and
axonal
cytoskeleton.
...
PMID:Dynein light chain LC8 regulates syntaphilin-mediated mitochondrial docking in axons. 1964 Nov 6
Reduced
axonal
mitochondrial transport has been observed in major neurodegenerative diseases, including fALS patients and SOD1(G93A) mice. However, it is unclear whether this defect plays a critical role in
axonal
degeneration or simply reflects sequelae of general transport alteration. Using genetic mouse models combined with time-lapse imaging of live neurons, we previously discovered that axon-targeted
syntaphilin
(
SNPH
) acts as a docking receptor specific for
axonal
mitochondria. Deletion of the snph gene in mice results in a substantially higher proportion of
axonal
mitochondria in the mobile state without any effect on the transport of other
axonal
organelles. Here we address whether increased (rescued)
axonal
mitochondrial mobility changes the disease course by crossing fALS-linked transgenic SOD1(G93A) and snph(-/-) knock-out mice. We found that a 2-fold increase in
axonal
mitochondrial mobility in SOD1(G93A)/snph(-/-) mice did not affect the onset of ALS-like symptoms. Both SOD1(G93A) and SOD1(G93A)/snph(-/-) mice exhibit similar weight loss, deterioration in motor function and motor neuron loss, significant gliosis, and a lifespan of 152-154 days. Thus, for the first time, our study provides genetic and pathological evidence that the impairment of mitochondrial transport seen in SOD1(G93A) mice plays a minimal role in the rapid-onset of fALS-linked pathology.
...
PMID:Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice. 2151 71
Axonal mitochondria are recruited to synaptic terminals in response to neuronal activity, but the mechanisms underlying activity-dependent regulation of mitochondrial transport are largely unknown. In this paper, using genetic mouse model combined with live imaging, we demonstrate that
syntaphilin
(
SNPH
) mediates the activity-dependent immobilization of
axonal
mitochondria through binding to KIF5. In vitro analysis showed that the KIF5-
SNPH
coupling inhibited the motor adenosine triphosphatase. Neuronal activity further recruited
SNPH
to
axonal
mitochondria. This motor-docking interplay was induced by Ca(2+) and synaptic activity and was necessary to establish an appropriate balance between motile and stationary
axonal
mitochondria. Deleting snph abolished the activity-dependent immobilization of
axonal
mitochondria. We propose an "Engine-Switch and Brake" model, in which
SNPH
acts both as an engine off switch by sensing mitochondrial Rho guanosine triphosphatase-Ca(2+) and as a brake by anchoring mitochondria to the microtubule track. Altogether, our study provides new mechanistic insight into the molecular interplay between motor and docking proteins, which arrests
axonal
mitochondrial transport in response to changes in neuronal activity.
...
PMID:Kinesin-1-syntaphilin coupling mediates activity-dependent regulation of axonal mitochondrial transport. 2385 72
One of the most notable characteristics of synaptic transmission is the wide variation in synaptic strength in response to identical stimulation. In hippocampal neurons, approximately one-third of
axonal
mitochondria are highly motile, and some dynamically pass through presynaptic boutons. This raises a fundamental question: can motile mitochondria contribute to the pulse-to-pulse variability of presynaptic strength? Recently, we identified
syntaphilin
as an
axonal
mitochondrial-docking protein. Using hippocampal neurons and slices of
syntaphilin
knockout mice, we demonstrate that the motility of
axonal
mitochondria correlates with presynaptic variability. Enhancing mitochondrial motility increases the pulse-to-pulse variability, whereas immobilizing mitochondria reduces the variability. By dual-color live imaging at single-bouton levels, we further show that motile mitochondria passing through boutons dynamically influence synaptic vesicle release, mainly by altering ATP homeostasis in axons. Thus, our study provides insight into the fundamental properties of the CNS to ensure the plasticity and reliability of synaptic transmission.
...
PMID:Motile axonal mitochondria contribute to the variability of presynaptic strength. 2389 Oct
Axonal degeneration is a primary cause of permanent neurological disability in individuals with the CNS demyelinating disease multiple sclerosis. Dysfunction of
axonal
mitochondria and imbalanced energy demand and supply are implicated in degeneration of chronically demyelinated axons. The purpose of this study was to define the roles of mitochondrial volume and distribution in
axonal
degeneration following acute CNS demyelination. We show that the
axonal
mitochondrial volume increase following acute demyelination of WT CNS axons does not occur in demyelinated axons deficient in
syntaphilin
, an
axonal
molecule that immobilizes stationary mitochondria to microtubules. These findings were supported by time-lapse imaging of WT and
syntaphilin
-deficient axons in vitro. When demyelinated, axons deficient in
syntaphilin
degenerate at a significantly greater rate than WT axons, and this degeneration can be rescued by reducing
axonal
electrical activity with the Na(+) channel blocker flecainide. These results support the concept that
syntaphilin
-mediated immobilization of mitochondria to microtubules is required for the volume increase of
axonal
mitochondria following acute demyelination and protects against
axonal
degeneration in the CNS.
...
PMID:Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons. 2495 79
The impairment of mitochondrial function is an important pathogenic factor in glaucoma and other optic neuropathies in which retinal ganglion cell (RGC) death is the fundamental pathology.
Syntaphilin
was recently discovered as a docking protein that affects mitochondrial mobility. However, no reports have investigated the involvement of
syntaphilin
in the visual system. We investigated the expression of
syntaphilin
in the rat retina, optic nerve and brain. The expression of
syntaphilin
exhibited varying patterns in the visual system.
Syntaphilin
was expressed in retinal ganglion cells in the retina, in the cell bodies of neurons in the superior colliculus and was abundant in the astrocytes of rat optic nerves (similar to the findings that
syntaphilin
is expressed in human optic nerves). After optic nerve transection, which caused RGC death and
axonal
degeneration, quantitative real-time RT-PCR was used to assess changes in gene expression in the rat retina and optic nerve.
Syntaphilin
gene and protein expression in the optic nerve was downregulated 3 and 7 days after optic nerve transection. Our study suggests that
syntaphilin
expression in astrocytes at the optic nerve might be involved in
axonal
injury.
...
PMID:The expression of syntaphilin is down-regulated in the optic nerve after axonal injury. 2544 62
Although neuronal regeneration is a highly energy-demanding process,
axonal
mitochondrial transport progressively declines with maturation. Mature neurons typically fail to regenerate after injury, thus raising a fundamental question as to whether mitochondrial transport is necessary to meet enhanced metabolic requirements during regeneration. Here, we reveal that reduced mitochondrial motility and energy deficits in injured axons are intrinsic mechanisms controlling regrowth in mature neurons. Axotomy induces acute mitochondrial depolarization and ATP depletion in injured axons. Thus, mature neuron-associated increases in mitochondria-anchoring protein
syntaphilin
(
SNPH
) and decreases in mitochondrial transport cause local energy deficits. Strikingly, enhancing mitochondrial transport via genetic manipulation facilitates regenerative capacity by replenishing healthy mitochondria in injured axons, thereby rescuing energy deficits. An in vivo sciatic nerve crush study further shows that enhanced mitochondrial transport in snph knockout mice accelerates axon regeneration. Understanding deficits in mitochondrial trafficking and energy supply in injured axons of mature neurons benefits development of new strategies to stimulate axon regeneration.
...
PMID:Facilitation of axon regeneration by enhancing mitochondrial transport and rescuing energy deficits. 2726 98
In neuronal axons, the ratio of motile-to-stationary mitochondria is tightly regulated by neuronal activation, thereby meeting the need for local calcium buffering and maintaining the ATP supply. However, the molecular players and detailed regulatory mechanisms behind neuronal mitochondrial movement are not completely understood. Here, we found that neuronal activation-induced mitochondrial anchoring is regulated by Disrupted-in-schizophrenia 1 (DISC1), which is accomplished by functional association with
Syntaphilin
(
SNPH
). DISC1 deficiency resulted in reduced
axonal
mitochondrial movement, which was partially reversed by concomitant
SNPH
depletion. In addition, a
SNPH
deletion mutant lacking the sequence for interaction with DISC1 exhibited an enhanced mitochondrial anchoring effect than wild-type
SNPH
. Moreover, upon neuronal activation, mitochondrial movement was preserved by DISC1 overexpression, not showing immobilized response of mitochondria. Taken together, we propose that DISC1 in association with
SNPH
is a component of a modulatory complex that determines mitochondrial anchoring in response to neuronal activation.
...
PMID:Disrupted-in-schizophrenia 1 (DISC1) and Syntaphilin collaborate to modulate axonal mitochondrial anchoring. 2737 Aug 22
1
2
Next >>